|
SARS-CoV-2 Antibodies to Treat or Diagnose COVID-19
This invention includes multiple high affinity, human antibodies that selectively target the SARS-CoV-2 virus which is responsible for COVID-19. Each antibody was identified by screening an internally developed human single chain variable fragment (scFv) library against different components of the SARS-CoV-2 virus particle. Successful screening protocols...
Published: 5/6/2024
|
Inventor(s): Xian Li, Xiaohua Lou
Keywords(s):
Category(s): Clinical Area > Infectious Disease, Research Area > Infectious Diseases and Pathology, Technology Classifications > Research Tool > Antibodies, Technology Classifications > Therapeutic > Biologics, Technology Classifications > Therapeutic > Antibodies
|
